RxEconomics Solutions
RxEconomics is a boutique health economics and policy research firm providing advanced analytical solutions with a laser focus on creating value for our clients and delivering results with precision and speed. Led by Dr. M. Christopher Roebuck, who brings over 28 years of experience in health economics, our team combines deep expertise in econometrics and biostatistics with innovative AI tools to deliver insights quickly and cost-effectively.
As a nimble firm, we offer personalized, senior-level attention on every project – ensuring high-quality, actionable results—typically 3× faster than traditional approaches. Our solutions span five service areas, each with its own dedicated practice: Real-World Evidence & Claims Analytics, Health Economics & Outcomes Research, AI-Powered HEOR, Health Policy Analysis & Market Access, and Litigation Support & Expert Witness. Across all these domains, we leverage cutting-edge analytics (including machine learning and generative AI) to provide you with data-driven evidence that drives better decisions and tangible outcomes.
Real-World Evidence & Claims Analytics
Real-world evidence complements clinical trial data with insights from actual clinical practice—insurance claims, electronic health records, patient registries, and national surveys that show how treatments perform in diverse populations and routine care settings. We design and execute claims-based studies end to end: framing the question, selecting the right dataset, constructing defensible cohorts, applying rigorous causal methods, and delivering publication-ready results.
We name our datasets—MarketScan, Optum, Medicare, Medicaid, MEPS, NHIS—because dataset selection determines whether your study can answer its question at all. Our capabilities span retrospective claims studies, comparative effectiveness research, medication adherence analysis, and external control arms.
Explore our real-world evidence and claims data analytics consulting.
Health Economics & Outcomes Research
Health economics and outcomes research demonstrates the value of healthcare interventions through data-driven analysis—evaluating the costs, outcomes, and quality-of-life impacts of health treatments so decision-makers can see which options deliver the best value. In an era of value-based care and rising costs, robust HEOR is essential for proving the clinical and economic benefits of new therapies, programs, or policies.
We design and execute economic models, cost-effectiveness analyses, budget impact models, value dossiers, and outcomes studies that meet the highest methodological standards while staying commercially relevant—and we translate the results into clear, compelling value stories for payers, HTA bodies, and formulary committees.
AI-Powered HEOR
Artificial intelligence now accelerates every stage of the HEOR workflow—systematic literature reviews, claims coding, cohort construction, economic modeling, and research synthesis. What it has not changed is what makes evidence trustworthy. Our Expert-Verified AI for HEOR approach makes every AI-assisted output traceable, inspectable, and expert-checked before it reaches you, so you get results typically 3× faster—without sacrificing rigor.
Health Policy Analysis & Market Access
Policy changes—from new legislation and government programs to updates in payer coverage criteria—can profoundly affect how healthcare is delivered and paid for. We model these forces quantitatively: IRA and Medicare Drug Price Negotiation exposure, most-favored-nation pricing scenarios, 340B economics, and Medicaid rebate dynamics, alongside the pricing strategy, reimbursement pathway, and HTA response work that earns formulary position.
Our market access strategies rest on payer evidence built by the economists who create the underlying models—so the value story you take into a negotiation is coherent, current, and defensible.
Litigation Support & Expert Witness
In high-stakes healthcare cases—pharmaceutical litigation, insurance reimbursement disputes, healthcare antitrust matters, or policy challenges—you need an expert who can dissect complex economic issues and present findings clearly and credibly. Dr. Roebuck provides expert reports, testimony, and litigation consulting support in healthcare damages, reimbursement, claims-based economic analysis, and rebuttal settings.
Our litigation work includes economic damages assessment, attributable-cost modeling, claims-based damages analyses, and critical evaluation of opposing experts' methodologies—analytical rigor built to withstand Daubert scrutiny.
Explore our health economics expert witness and litigation support services.